Neuropeptides for Alzheimer's Disease Research - NEWLY UPDATED!
As the sixth leading cause of death in the United States, Alzheimer’s disease, a chronic neurodegenerative disease, affects more than 5 million people in the United States alone. It is estimated that Alzheimer’s disease and other dementias will cost $236 million in medical care in 2016. Alzheimer’s disease is a progressive brain disorder that causes problems with memory, thinking, and behavior. Extracellular amyloid plaques, caused by the Amyloid β-Protein, and intracellular neurofibrillary tangles are hallmark features of the disease.1
The buildup of plaques in the brain from Amyloid β-Protein cause inflammation and neurodegeneration. Recently, P. Bhattarai and his team in Dresden, Germany, have discovered that, in zebrafish, Interleukin-4 (IL-4) is activated by neurons in response to Amyloid β-Protein, resulting in increased neuron proliferation. This discovery can lead to further research in treating human neural degradation due to Alzheimer’s.2 If scientists can figure out how to activate IL-4 in humans, the lost neurons can possibly be replaced.
In families where early-onset Alzheimer’s disease is prevalent, it is thought that a mutation in the PSEN1 gene creates a defective presenilin-1 protein. This in turn causes a disruption in the function of the γ-secretase complex.3 DAPT is an inhibitor of presenilin-dependent γ-secretase which has been shown to block Amyloid β-Protein production in neuronal cultures.4
- P. Bhattarai, et al., Cell Reports, 17, 941 (2016). Retrieved from http://www.cell.com/cell-reports/pdf/S2211-1247(16)31331-6.pdf
- A.Y. Kornilova, et al, J. Biol. Chem., 278, 16470 (2003). Retrieved from http://www.jbc.org/content/278/19/16470.long
You can also view our products for Alzheimer's research in the online catalog here.
Authors from Peptides International
A New Fibril Structure of Amyloid β-Protein (1-42)A new polymorph identified
Exenatide as a Treatment for Parkinson’s DiseaseA case for evaluating GLP-1 agonists as Parkinson's Disease treatments
Various NeuropeptidesA listing of neuropeptides for neuroscience research. This is a companion to our "Neuropeptides fro Alzheimer's Disease Research" brochure.
Developments In Alzheimer's Disease ResearchDr. Andrzej Czerwinski has a new post concentrating on five publications relating to the research for the treatment of Alzheimer's disease.
Neuroscience Research Peptides (A Quick Reference)Peptides International has a wide range of products of interest to the neuroscience researcher.
Amyloid β-Protein Related PeptidesThe product brochure for the Amyloid β-Protein Related Peptides offered by Peptides International